⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HALO News
Halozyme Therapeutics, Inc.
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
prnewswire.com
HALO
Key Industry Players Drive Competitive Landscape in High-End Refractometer Market
globenewswire.com
MTD
HALO
Form 8-K
sec.gov
ACAA
ACAAU
ACAAW
HALO
IBM
Hellbender Secures $12.5M Seed Round to Accelerate Domestic Manufacturing of Physical AI and Launch Its On-Edge Camera Line
prnewswire.com
HALO
Form 8-K
sec.gov
HALO
HALOZYME REPORTS FIRST QUARTER 2026 RESULTS AND REITERATES 2026 FINANCIAL GUIDANCE
prnewswire.com
HALO
Form 8-K
sec.gov
HALO
Halozyme Announces Global Collaboration and License Agreement with GSK to Develop Subcutaneous Formulations of Multiple Promising Oncology Targets
prnewswire.com
HALO
Halozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
prnewswire.com
ORKA
HALO
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG
businesswire.com
HALO